Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-003471)

Filing Details

Accession Number:: 0001209191-14-003471
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-16 16:13:32
Reporting Period:: 2014-01-14

Filing Date:: 2014-01-16
Accepted Time:: 2014-01-16 16:13:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Laboratory Analytical Instruments (3826)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187574	Stuart Essig	311 C Enterprise Drive Plainsboro NJ 08536		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-14	10,600	$31.38	1,161,766	No	4	M	Direct
Common Stock	Disposition	2014-01-14	10,600	$49.50	1,151,166	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-01-14	10,600	$0.00	10,600	$31.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,937		2014-07-27	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
25% of the option grant vested on 7/27/2005 (the first anniversary of the grant date of 07/27/2004), and the remaining 75% vested monthly thereafter over 36 months.